Comparison of Commercial Low Molecular Weight Heparin and Homemade Anti-Xa Calibrators to a Commercial Specific Anti-Xa Calibrator for Plasma Rivaroxaban Quantification by Anti-Xa Oral Anticoagulant Plasma Concentration Chromogenic Assay

被引:1
|
作者
Divsalar, Bita [1 ,2 ]
Kalantari, Tahereh [1 ,2 ]
Mohebbi, Soheila [1 ,2 ]
Bahmanimehr, Ardeshir [3 ]
Shahsavani, Amin [3 ,4 ]
Borhani-Haghighi, Afshin [5 ]
机构
[1] Shiraz Univ Med Sci, Sch Paramed Sci, Dept Lab Sci, Div Hematol & Blood Banking, Shiraz, Iran
[2] Shiraz Univ Med Sci, Sch Paramed Sci, Diagnost Lab Sci & Technol Res Ctr, Shiraz, Iran
[3] Shiraz Univ Med Sci, Dastgheib Hosp, PND Res Ctr, Thalassemia & Hemophilia Genet, Shiraz, Iran
[4] Shiraz Univ Med Sci, Hematol Res Ctr, Shiraz, Iran
[5] Shiraz Univ Med Sci, Clin Neurol Res Ctr, Shiraz, Iran
关键词
Anti-Xa; homemade calibrator made by spiked normal pooled plasma; NPP; laboratory; low molecular weight heparin; rivaroxaban; CLINICAL-PRACTICE; APIXABAN;
D O I
10.1093/labmed/lmac137
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objective The main concern about measuring the concentration of rivaroxaban by anti-Xa assay in some laboratories is the lack of a commercial specific calibrator in emergencies. Therefore, this study aimed at providing a homemade anti-Xa calibrator and commercial low molecular weight heparin (LMWH) anti-Xa calibrator. Methods The anti-Xa plasma concentration of rivaroxaban was measured in 70 patients using a commercial specific anti-Xa calibrator, a commercial LMWH anti-Xa calibrator, and a homemade anti-Xa calibrator. Results We demonstrated a significant correlation and agreement (P < .001) between LMWH-calibrated anti-Xa and the commercial specific calibrator. A significant correlation (P < .001) was found between homemade calibrated anti-Xa made by normal pooled plasma and that calibrated with a commercial specific drug. The nonspecific homemade and LMWH calibrators had excellent agreement (P < .001) and can be used interchangeably. Conclusion Our data showed that for estimating rivaroxaban concentrations, the LMWH calibrator could be used as an alternative calibrator in the anti-Xa assay.
引用
收藏
页码:400 / 405
页数:6
相关论文
共 50 条
  • [1] Anti-Xa Oral Anticoagulant Plasma Concentration Assay in Real Life: Rivaroxaban and Apixaban Quantification in Emergency With LMWH Calibrator
    Billoir, Paul
    Barbay, Virginie
    Joly, Luc Marie
    Fresel, Marielle
    Chretien, Marie Helene
    Duchez, Veronique Le Cam
    [J]. ANNALS OF PHARMACOTHERAPY, 2019, 53 (04) : 341 - 347
  • [2] Universal anti-Xa assay for rivaroxaban and apixaban plasma concentration
    Studt, Jan-Dirk
    Stein, Philipp
    Hegemann, Inga
    Koch, Karin
    Sangalli-Baruffaldi, Jessica
    Nagler, Michael
    [J]. SWISS MEDICAL WEEKLY, 2018, 148 : 37S - 37S
  • [3] IMPROVEMENT OF CHROMOGENIC ANTI-XA ASSAY TO MEASURE BETRIXABAN CONCENTRATION IN PLASMA
    Siriez, Romain
    Evrard, Jonathan
    Dogne, Jean-Michel
    Pochet, Lionel
    Mullier, Francois
    Douxfils, Jonathan
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2019, 41 : 160 - 160
  • [4] A MECHANIZED CHROMOGENIC ASSAY FOR THE DETECTION OF ANTI-XA ACTIVITY IN PLASMA
    TENCATE, H
    LAMPING, RJ
    HENNY, CP
    PRINS, A
    TENCATE, JW
    [J]. THROMBOSIS AND HAEMOSTASIS, 1983, 50 (01) : 235 - 235
  • [5] Evaluation of a new anti-Xa heparin assay
    Davidson, S. J.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 996 - 996
  • [6] Heparin interference in anti-XA assays for rivaroxaban and apixaban
    Cutsforth, G. A.
    Finnegan, K.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 795 - 795
  • [7] Stability of Plasma Anti-Xa Activity in Low-Molecular-Weight Heparin Monitoring
    Rojnuckarin, Ponlapat
    Akkawat, Benjaporn
    Juntiang, Jumlong
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2010, 16 (03) : 313 - 317
  • [8] ASSESSMENT OF APIXABAN PLASMA LEVELS BY ANTI-XA ACTIVITY TESTS: COMPARISON OF ROTACHROM AND STA LIQUID ANTI-XA ASSAYS
    Wang, Zhaoqing
    Green, George
    Connolly, Thomas
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (06) : E76 - E77
  • [9] Validation of an assay for determination of anti-xa activity of Rivaroxaban
    Delavenne, X.
    Meuley, R.
    Baylot, D.
    Mismetti, P.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 965 - 966
  • [10] LABORATORY VALIDATION OF A CHROMOGENIC ANTI-XA ASSAY FOR APIXABAN
    Leger, Rachel R.
    Tange, Julie I.
    McBane, Robert D.
    Chen, Dong
    Pruthi, Rajiv K.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (09) : E36 - E37